Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Dr Reddys Laboratories (RDY) over the last 14 years, with Q4 2025 value amounting to -$427.0 million.

  • Dr Reddys Laboratories' Total Non-Current Liabilities changed N/A to -$427.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$427.0 million, marking a year-over-year change of. This contributed to the annual value of $298.0 million for FY2025, which is 12575.76% up from last year.
  • Dr Reddys Laboratories' Total Non-Current Liabilities amounted to -$427.0 million in Q4 2025.
  • In the past 5 years, Dr Reddys Laboratories' Total Non-Current Liabilities ranged from a high of $332.4 million in Q3 2025 and a low of -$427.0 million during Q4 2025
  • In the last 5 years, Dr Reddys Laboratories' Total Non-Current Liabilities had a median value of $85.6 million in 2022 and averaged -$8.9 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 10053907315.89% in 2023, then surged by 17700.64% in 2024.
  • Dr Reddys Laboratories' Total Non-Current Liabilities (Quarter) stood at -$325.0 million in 2021, then fell by 6.0% to -$344.5 million in 2022, then surged by 134.25% to $118.0 million in 2023, then surged by 177.01% to $326.8 million in 2024, then crashed by 230.66% to -$427.0 million in 2025.
  • Its Total Non-Current Liabilities stands at -$427.0 million for Q4 2025, versus $332.4 million for Q3 2025 and $293.7 million for Q1 2025.